Patient info

Sertraline 100 mg film-coated tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
100 mg
Contains active substance:
ATC code:

Patient leaflet - Sertraline 100 mg film-coated tablets

1. What Sertraline Tablets is and what it is used for

Sertraline Tablets contains the active substance sertraline. Sertraline is one of a group of medicines called Selective Serotonin Re-uptake Inhibitors (SSRIs); these medicines are used to treat depression and/or anxiety disorders. Sertraline Tablets can be used to treat:

  • Depression and prevention of recurrence of depression (in

    adults).

  • Social anxiety disorder (in adults).
  • Post-traumatic stress disorder (PTSD) (in adults). • Panic disorder (in adults).
  • Obsessive compulsive disorder (OCD) (in adults and

    children and adolescents aged 6-17 years old). Depression is a clinical illness with symptoms like feeling sad, unable to sleep properly or to enjoy life as you used to. OCD and Panic disorders are illnesses linked to anxiety with symptoms like being constantly troubled by persistent ideas (obsessions) that make you carry out repetitive rituals (compulsions).

PTSD is a condition that can occur after a very emotionally traumatic experience and has some symptoms that are similar to depression and anxiety. Social anxiety disorder (social phobia) is an illness linked to anxiety. It is characterised by feelings of intense anxiety or distress in social situations (for example: talking to strangers, speaking in front of groups of people, eating or drinking in front of others or worrying that you might behave in an embarrassing manner).

Your doctor has decided that this medicine is suitable for treating your illness.

You should ask your doctor if you are unsure why you have been given Sertraline Tablets.

2. What you need to know before you take

Sertraline Tablets

Do not take Sertraline Tablets:

  • If you are allergic to Sertraline or any of the other

    ingredients of this medicine (listed in section 6). • If you are taking or have taken medicines called

    monoamine oxidase inhibitors (MAOIs such as selegiline, moclobemide) or MAOI like drugs (such as linezolid). If you stop treatment with sertraline, you must wait until at least one week before you start treatment with a MAOI. After stopping treatment with a MAOI, you must wait at least 2 weeks before you can start treatment with sertraline. • If you are taking another medicine called pimozide (a

    medicine for mental disorders such as psychosis). Warnings and precautions

Talk to your doctor or pharmacist before taking Sertraline Tablets. Medicines are not always suitable for everyone. Tell your doctor before you take Sertraline Tablets, if you suffered from or have suffered in the past from any of the following conditions: • If you have epilepsy (fit) or a history of seizures. If you have

a fit (seizure), contact your doctor immediately. • If you have suffered from manic depressive illness (bipolar

disorder) or schizophrenia. If you have a manic episode, contact your doctor immediately.

  • If you have or have previously had thoughts of harming or

    killing yourself (see below-Thoughts of suicide and worsening of your depression or anxiety disorder). • If you have Serotonin Syndrome. In rare cases this

    syndrome may occur when you are taking certain medicines at the same time as sertraline. (For symptoms, see section

    1. 4. Possible Side Effects). Your doctor will have told you

whether you have suffered from this in the past. • If you have low sodium level in your blood, since this can

occur as a result of treatment with Sertraline Tablets. You should also tell your doctor if you are taking certain medicines for hypertension, since these medicines may also alter the sodium level in your blood.

  • If you are elderly as you may be more at risk of having low

    sodium level in your blood (see above).

  • If you have liver disease; your doctor may decide that you

    should have a lower dose of Sertraline Tablets. • If you have diabetes; your blood glucose levels may be

    altered due to Sertraline Tablets and your diabetes medicines may need to be adjusted.

  • If you have a history of bleeding disorders (tendency to

    develop bruises), or if you are pregnant (see Pregnancy, breast-feeding and fertility) or have been taking medicines which thin the blood (e.g. acetylsalicyclic acid (aspirin), or warfarin) or may increase the risk of bleeding. • If you are a child or adolescent under 18 years old.

    Sertraline Tablets should only be used to treat children and adolescents aged 6-17 years old, suffering from obsessive compulsive disorder (OCD). If you are being treated for this disorder, your doctor will want to monitor you closely (see below-Children and adolescents).

  • If you are having electro-convulsive therapy (ECT). • If you have eye problems, such as certain kinds of

    glaucoma (increased pressure in the eye).

  • If you have been told that you have an abnormality of your

    heart tracing after an electrocardiogram (ECG) known as prolonged QT interval.

  • If you have heart disease, low potassium levels or low

    magnesium levels, family history of QT prolongation, low heart rate and concomitant use of medications which prolong QT interval.

Restlessness/Akathisia:

The use of sertraline has been linked to a distressing restlessness and need to move, often being unable to sit or stand still (akathisia). This is most likely to occur during the first few weeks of treatment. Increasing the dose may be harmful so if you develop such symptoms you should talk to your doctor. Withdrawal reactions:

Side effects relating to stopping treatment (withdrawal reactions) are common, particularly if the treatment is stopped suddenly (see section 3 If you stop taking Sertraline Tablets and section 4 Possible side effects). The risk of withdrawal symptoms depends on the length of treatment, dosage, and the rate at which the dose is reduced. Generally, such symptoms are mild to moderate. However, they can be serious in some patients. They normally occur within the first few days after stopping treatment. In general, such symptoms disappear on their own and wear off within 2weeks. In some patients they may last longer (2-3 months or more). When stopping treatment with sertraline it is recommended to reduce the dose gradually over a period of several weeks or months, and you should always discuss the best way of stopping treatment with your doctor.

Thoughts of suicide and worsening of your depression or anxiety disorder:

If you are depressed and/or have anxiety disorders you can sometimes have thoughts of harming or killing yourself. These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.

You may be more likely to think like this:

  • If you have previously had thoughts about killing or harming

    yourself.

  • If you are a young adult. Information from clinical trials has

    shown an increased risk of suicidal behaviour in adults aged less than 25 years with psychiatric conditions who were treated with an antidepressant.

If you have thoughts of harming or killing yourself at any time,

contact your doctor or go to a hospital straight away. You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.

Sexual problems:

Medicines like Sertraline Tablets (so called SSRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms have continued after stopping treatment. Children and adolescents:

Sertraline should not usually be used in children and adolescents less than 18 years old, except for patients with Obsessive Compulsive Disorder (OCD). Patients under 18 have an increased risk of undesirable effects, such as suicide attempt, thoughts of harming or killing themselves (suicidal thoughts) and hostility (mainly aggressiveness, oppositional behaviour and anger) when they are treated with this class of medicines. Nevertheless, it is possible that your doctor decides to prescribe Sertraline Tablets to a patient under 18 if it is in the patient’s interest. If your doctor has prescribed Sertraline Tablets to you and you are less than 18 years old and you want to discuss this, please contact him/her. Furthermore, if any of the symptoms listed above appear or worsen while you are taking Sertraline Tablets, you should inform your doctor. The long-term safety of Sertraline Tablets in regard to growth, maturation and learning (cognitive) and behavioural development was evaluated in a long term study in more than 900 children aged 6 to 16 years of age who were monitored over a 3 year period. Overall, the results of the study showed that children treated with sertraline developed normally other than mild weight gain in those treated with a higher dose.

Other medicines and Sertraline Tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Some medicines can affect the way Sertraline Tablets works, or Sertraline Tablets itself can reduce the effectiveness of other medicines taken at the same time.

Taking Sertraline Tablets together with the following medicines may cause serious side effects:

  • Medicines called monoamine oxidase inhibitors (MAOIs),

    like moclobemide (to treat depression) and selegiline (to treat Parkinson’s disease), the antibiotic linezolid and methylene blue (to treat high levels of methaemoglobin in the blood). Do not use Sertraline Tablets together with these medicines.

  • Medicines to treat mental disorders such as psychosis

    (pimozide). Do not use Sertraline Tablets together with pimozide.

Talk to your doctor if you are taking the following medicines:

  • Medicines containing amphetamines (used to treat attention

    deficit hyperactivity disorder (ADHD), narcolepsy, and obesity).

  • Herbal medicine containing St. John’s Wort (Hypericum

    perforatum). The effects of St. John’s Wort may last for 1–2 weeks.

  • Products containing the amino acid tryptophan. • Medicines to treat severe or chronic pain (opioids e.g.

    tramadol, fentanyl).

  • Medicines used in anaesthesia (e.g. fentanyl, mivacurium

    and suxamethonium).

  • Medicines to treat migraines (e.g. sumatriptan). • Blood thinning medicine (warfarin).
  • Medicines to treat pain/arthritis (eg. Metimazole, Non

    steroidal anti-inflammatory drug (NSAID) such as ibuprofen, acetylsalicylic acid (aspirin)).

  • Sedatives (diazepam).
  • Diuretics (also called ‘water’ tablets).
  • Medicines to treat epilepsy (phenytoin, phenobarbital,

    carbamazepine).

  • Medicines to treat diabetes (tolbutamide).
  • Medicines to treat excessive stomach acid, ulcers and

    heartburn (cimetidine, omeprazole, lanzoprazole, pantoprazole, rabeprazole).

  • Medicines to treat mania and depression (lithium). • Other medicines to treat depression (such as amitriptyline,

    nortriptyline, nefazodone, fluoxetine, fluvoxamine). • Medicines to treat schizophrenia and other mental disorders

    (such as perphenazine, levomepromazine and olanzapine). • Medicines used to treat high blood pressure, chest pain or

    regulate the rate and rhythm of the heart (such as verapamil, diltiazem, flecainide, propafenone). • Medicines used to treat bacterial infections (such as

    rifampicin, clarithromycin, telithromycin, erythromycin). • Medicines used to treat fungal infections (such as

    ketoconazole, itraconazole, posaconazole, voriconazole, fluconazole).

  • Medicines used to treat HIV/AIDS and Hepatitis C (protease

    inhibitors such as ritonavir, telaprevir).

  • Medicines used to prevent nausea and vomiting after an

    operation or chemotherapy (aprepitant).

  • Medicines known to increase the risk of changes in the

    electrical activity of the heart (e.g. some antipsychotics and antibiotics).

Sertraline Tablets with food, drink and alcohol:

Sertraline tablets can be taken with or without food. Alcohol should be avoided whilst taking Sertraline Tablets. Sertraline should not be taken in combination with grapefruit juice, as this may increase the level of sertraline in your body. Pregnancy, breast-feeding and fertility:

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

The safety of sertraline has not fully been established in pregnant women. Sertraline will only be given to you when pregnant if your doctor considers that the benefit for you is greater than any possible risk to the developing baby. If you take Sertraline Tablets near the end of your pregnancy there may be an increased risk of heavy vaginal bleeding shortly after birth, especially if you have a history of bleeding disorders. Your doctor or midwife should be aware that you are taking Sertraline Tablets so they can advise you. When taken during pregnancy, particularly in the last 3 months of pregnancy, medicines like Sertraline Tablets may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and appear bluish. These symptoms usually begin during the first 24 hours after the baby is born. If this happens to your baby you should contact your midwife and/or doctor immediately. Your newborn baby might also have other conditions, which usually begin during the first 24 hours after birth. Symptoms include:

  • trouble with breathing,
  • a blueish skin or being too hot or cold,
  • blue lips,
  • vomiting or not feeding properly,
  • being very tired, not able to sleep or crying a lot, • stiff or floppy muscles,
  • tremors, jitters or fits,
  • increased reflex reactions,
  • irritability,
  • low blood sugar.

If your baby has any of these symptoms when it is born, or you are concerned about your baby’s health, contact your doctor or midwife who will be able to advise you.

There is evidence that sertraline passes into human breast milk. Sertraline should only be used in women during breast-feeding, if your doctor considers that the benefit exceeds any possible risk to the baby.

Some medicines like sertraline may reduce the quality of sperm

in animal studies. Theoretically, this could affect fertility, but impact on human fertility has not been observed as yet. Driving and using machines

Psychotropic drugs such as sertraline may influence your ability to drive or use machines. You should therefore not drive or operate machinery, until you know how this medication affects your ability to perform these activities.

Sertraline Tablets contains sodium:

Sertraline Tablets contains less than 1 mmol sodium (23 mg) per 50 mg and 100 mg film-coated tablets, that is to say essentially ‘sodium-free’.

3. How to take Sertraline Tablets

Always take this medicine exactly as your doctor or pharmacist has told you.

Check with your doctor or pharmacist if you are not sure. The recommended dose is:

Adults:

Depression and Obsessive Compulsive Disorder:

For depression and OCD, the usual effective dose is 50 mg/day. The daily dose may be increased in 50 mg increments and at intervals of at least one week over a period of weeks. The maximum recommended dose is 200 mg/day. Panic disorder, Social anxiety disorder and Post Traumatic Stress Disorder:

For panic disorder, social anxiety disorder and post-traumatic stress disorder, treatment should be started at 25 mg/day, and increased to 50 mg/day after one week.

The daily dose then may be increased in 50 mg increments over a period of weeks. The maximum recommended dose is 200 mg/day.

Use in children and adolescents:

Sertraline Tablets must only be used to treat children and adolescents suffering from OCD aged 6-17 years old. Obsessive Compulsive Disorder:

Children aged 6 to 12: the recommended starting dose is 25 mg daily.

After one week, your doctor may increase this to 50 mg daily. The maximum dose is 200 mg daily.

Adolescents aged 13 to 17: the recommended starting dose is 50 mg daily.

The maximum dose is 200 mg daily.

If you have liver or kidney problems, please tell your doctor and follow the doctor’s instructions.

Method of administration:

Sertraline Tablets may be taken with or without food. Take your medication once daily either in the morning or evening.

Your doctor will advise you on how long to take this medication for. This will depend on the nature of your illness and how well you are responding to the treatment. It may take several weeks before your symptoms begin to improve. Treatment of depression should usually continue for 6 months after improvement.

If you take more Sertraline Tablets than you should

If you accidentally take too much Sertraline Tablets contact your doctor at once or go to the nearest hospital casualty department. Always take the labelled medicine package with you, whether there is any medication left or not.

Symptoms of overdose may include drowsiness, nausea and vomiting, rapid heart rate, shaking, agitation, dizziness and in rare cases unconsciousness.

If you forget to take Sertraline Tablets:

Do not take a double dose to make up for a forgotten dose. If you forget to take a dose, do not take the missed dose. Just take the next dose at the right time.

If you stop taking Sertraline Tablets:

Do not stop taking Sertraline Tablets unless your doctor tells you to. Your doctor will want to gradually reduce your dose of Sertraline Tablets over several weeks, before you finally stop taking this medicine. If you suddenly stop taking this medicine you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, feeling sick, being sick and shaking. If you experience any of these side effects, or any other side effects whilst stopping taking Sertraline Tablets, please speak to your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Nausea is the most common side effect. The side effects depend on the dose and often disappear or lessen with continued treatment.

Tell your doctor immediately:

If you experience any of the following symptoms after taking this medicine, these symptoms can be serious.

  • If you develop a severe skin rash that causes blistering

    (erythema multiforme), (this can affect the mouth and tongue). These may be signs of a condition known as Stevens Johnson Syndrome, or Toxic Epidermal Necrolysis (TEN). Your doctor will stop your treatment in these cases. • Allergic reaction or allergy, which may include symptoms

    such as an itchy skin rash, breathing problems, wheezing, swollen eyelids, face or lips.

  • If you experience agitation, confusion, diarrhoea, high

    temperature and blood pressure, excessive sweating and rapid heartbeat. These are symptoms of Serotonin Syndrome. In rare cases this syndrome may occur when you are taking certain medicines at the same time as sertraline. Your doctor may wish to stop your treatment. • If you develop yellow skin and eyes which may mean liver

    damage.

  • If you experience depressive symptoms with ideas of

    harming or killing yourself (suicidal thoughts). • If you start to get feelings of restlessness and are not able

    to sit or stand still after you start to take Sertraline Tablets. You should tell your doctor if you start to feel restless. • If you have a fit (seizure).

  • If you have a manic episode (see section 2 “Warnings and

    precautions”).

The following side effects were seen in clinical trials in adults and after marketing.

Very common (may affect more than 1 in 10 people): Insomnia, dizziness, sleepiness, headache, diarrhoea, feeling sick, dry mouth, ejaculation failure, fatigue.

Common (may affect up to 1 in 10 people):

  • chest cold, sore throat, runny nose,
  • decreased appetite, increased appetite,
  • anxiety, depression, agitation, decreased sexual interest,

    nervousness, feeling strange, nightmare, teeth grinding, • shaking, muscular movement problems (such as moving a

    lot, tense muscles, difficulty walking and stiffness, spasms and involuntary movements of muscles)*, numbness and tingling, muscle tense, lack of attention, abnormal taste, • visual disturbance,

  • ringing in ears,
  • palpitations,
  • hot flush,
  • yawning,
  • upset stomach, constipation, abdominal pain, vomiting, gas, • increased sweating, rash,
  • back pain, joint pain, muscle pain,
  • menstrual irregularities, erectile dysfunction, • malaise, chest pain, weakness, fever,
  • weight increased,
  • injury.

Uncommon (may affect up to 1 in 100 people):

  • gastroenteritis, ear infection,
  • tumour,
  • hypersensitivity, seasonal allergy,
  • low thyroid hormones,
  • suicidal thoughts, suicidal behaviour*, psychotic disorder,

    thinking abnormal, lack of caring, hallucination, aggression, euphoric mood, paranoia,

  • amnesia, decreased feeling, involuntary muscle contractions,

    passing out, moving a lot, migraine, convulsion, dizziness while standing up, abnormal coordination, speech disorder, • enlarged pupils,

  • ear pain,
  • fast heartbeat, heart problem
  • bleeding problems (such as stomach bleeding)*, high blood

    pressure, flushing, blood in urine,

  • shortness of breath, nose bleed, breathing difficulty,

    possible wheezing,

    • tarry stools, tooth disorder, inflammation of the oesophagus, tongue problem, haemorrhoids, increased saliva, difficulty swallowing, burping, tongue disorder,
    • eye swelling, hives, hair loss, itching, purple spots on skin, skin problem with blisters, dry skin, face oedema, cold sweat,
    • osteoarthritis, muscle twitching, muscle cramps*, muscular weakness,
    • increase in frequency of urination, problem urinating unable to urinate, urinary incontinence, increase in urination, nighttime urination,
    • sexual dysfunction, excessive vaginal bleeding, vaginal haemorrhage, female sexual dysfunction,
    • swelling in legs, chills, difficulty walking, thirst, • increase in liver enzyme levels, weight decreased.
    • Cases of suicidal ideation and suicidal behaviours have been reported during sertraline therapy or early after treatment discontinuation (see section 2).

Rare (may affect up to 1 in 1,000 people):

  • diverticulitis, swollen lymph glands, decrease in clotting cells*, decrease in white blood cells*,
  • severe allergic reaction,
  • endocrine problems*,
  • high cholesterol, problems controlling blood sugar levels

    (diabetes), low blood sugar, increase in blood sugar levels*, low blood salt*,

  • physical symptoms due to stress or emotions, terrifying abnormal dreams*, drug dependence, sleep walking, premature ejaculation,
  • coma, abnormal movements, difficulty moving, increased sensation, sudden severe headache (which may be a sign of a serious condition known as Reversible Cerebral Vasoconstriction Syndrome (RCVS)) *, sensory disturbance,
  • spots in front of eyes, glaucoma, double vision, light hurts eye, blood in the eye, unequal sized pupils*, vision abnormal*, tear problem,
  • heart attack, light-headedness, fainting, or chest discomfort which could be signs of changes in the electrical activity (seen on electrocardiogram) or abnormal rhythm of the heart*, slow heartbeat,
  • poor circulation of arms and legs,
  • breathing fast, progressive scarring of lung tissue

    (Interstitial Lung Disease)*, closing up of throat, difficulty talking, breathing slow, hiccups,

  • A form of lung disease where eosinophils (a form of white blood cell) appear in the lung in increased numbers (eosinophilic pneumonia).
  • mouth ulceration, pancreatitis*, blood in stool, tongue ulceration, sore mouth,
  • problems with liver function, serious liver function problems*, yellow skin and eyes (jaundice)*, • skin reaction to sun*, skin oedema*, hair texture abnormal, skin odour abnormal, hair rash,
  • breakdown of muscle tissue*, bone disorder, • urinary hesitation, decreased urination,
  • breast discharge, dry vaginal area, genital discharge, red painful penis and foreskin, breast enlargement*, prolonged erection,
  • hernia, drug tolerance decreased,
  • increase in blood cholesterol levels, abnormal laboratory tests*, semen abnormal, problems with clotting*, • relaxation of blood vessels procedure.

Not known: frequency cannot be estimated from the available data:

  • lockjaw*,
  • bedwetting*,
  • partial loss of vision,
  • inflammation of the colon (causing diarrhoea*), • heavy vaginal bleeding shortly after birth (postpartum haemorrhage), see Pregnancy, breast-feeding and fertility in section 2 for more information*.
  • Muscle weakness and severe muscle pain, which can be a sign of multiple acyl-coenzyme A dehydrogenase deficiency (MADD)-like disorder.*

*Side effect reported after marketing.

Additional side effects in children and adolescents

In clinical trials with children and adolescents, the side effects were generally similar to adults (see above). The most common side effects in children and adolescents were headache, insomnia, diarrhoea and feeling sick.

Symptoms that can occur when treatment is discontinued

If you suddenly stop taking this medicine you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, feeling sick, being sick and shaking (see section 3. “If you stop taking Sertraline Tablets”). An increased risk of bone fractures has been observed in patients taking this type of medicines.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the: Yellow Card Scheme, at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Sertraline Tablets

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the pack after EXP. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage condition.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Sertraline Tablets contains

Sertraline Film Coated Tablets:

Each film-coated tablet contains 55.950 mg of sertraline hydrochloride equivalent to 50 mg sertraline

Each film-coated tablet contains 111.900 mg of sertraline hydrochloride equivalent to 100 mg sertraline

The other ingredients are:

Calcium hydrogen phosphate dihydrate (E341), microcrystalline cellulose PH 101 (E460), microcrystalline cellulose PH 102 (E460), hydroxypropyl cellulose (E463), sodium starch glycollate (Type A), magnesium stearate (E572), Opadry TF (265B280002) (Hypromellose, Calcium carbonate, Polysorbate 80, Polyethylene glycol)

What Sertraline Tablets looks like and contents of the pack

Sertraline Film Coated Tablets:

White to off white, Capsule shape, convex film coated tablets, break line on one side and debossed with “50” on other side with approximately 10.1mm x 4.6mm dimensions. The tablet can be divided into equal doses.

White to off white, Capsule shape, convex film coated tablets, break line on one side and debossed with “100” on other side with approximately 13.2mm x 5.3mm dimensions. The tablet can be divided into equal doses.

50 mg film-coated tablets:

Sertraline tablets are available in blister packs containing 14, 28, 30, 56, 60, 84 and 100 tablets.

100 mg film-coated tablets:

Sertraline tablets are available in blister packs containing 14, 28, 30, 56, 60, 84 and 100 tablets

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder

Orbit Pharma Limited

128 City Road, London,

United Kingdom, EC1V 2NX

Manufacturer

SCIOM Limited

Unit 4, Martinfield Business Centre,

Martinfield, Welwyn Garden City,

AL7 1HG, United Kingdom

This leaflet was last revised in Mar 2026.

Mar 2026 0004

Version No. :

Sequence :

Date :

Product Name :

Sertraline Hydrochloride 50 mg & 100 mg film coated Tablets

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 56854/0023

Last revision stated in the text: March 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Sertraline 100 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Sertraline
Strength 100 mg
Pharmaceutical form Oral tablet
Sertraline 100 mg film-coated tablets are white film-coated oblong, biconvex tablets.
How is it taken Oral
Excipients Microcrystalline cellulose, Dibasic calcium phosphate dihydrate, Hydroxypropylcellulose, Sodium starch glycollate, Magnesium stearate, Opadry White YS-1R-7003 - Hydroxypropyl methylcellulose 2910, 3cP, Hydroxypropyl methylcellulose 2910, 5cP, Polyethylene glycol 400, Titanium dioxide, Polysorbate 80, Opadry Clear YS-1R-7006 - Hydroxypropyl methylcellulose 2910, 5cP, Polyethylene glycol 6000
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Two years
Storage Do not store above 25°C.
Keep out of the reach and sight of children.
Drug group (ATC) Selective serotonin reuptake inhibitors
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06A Antidepressants
        1. N06AB Selective serotonin reuptake inhibitors
          1. N06AB06 sertraline
Marketing authorisation PL 53797/0013, PL 56854/0023
Marketing authorisation holder Austin McNeil Ltd.
Codes BNF 04030300

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.